-
1
-
-
84871382056
-
Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: Bad news, good news, or no news?
-
I.R. Vogelius, and S.M. Bentzen Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: bad news, good news, or no news? Int J Radiat Oncol Biol Phys 85 2013 89 94
-
(2013)
Int J Radiat Oncol Biol Phys
, vol.85
, pp. 89-94
-
-
Vogelius, I.R.1
Bentzen, S.M.2
-
2
-
-
84869144788
-
Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer
-
S Arcangeli, L Strigari, and S. Gomellini Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer Int J Radiat Oncol Biol Phys 84 2012 1172 1178
-
(2012)
Int J Radiat Oncol Biol Phys
, vol.84
, pp. 1172-1178
-
-
Arcangeli, S.1
Strigari, L.2
Gomellini, S.3
-
3
-
-
78649982102
-
Confirmation of a low α/β ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics
-
C. Proust-Lima, J.M. Taylor, and S. Sécher Confirmation of a low α/β ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics Int J Radiat Oncol Biol Phys 79 2011 195 201
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.79
, pp. 195-201
-
-
Proust-Lima, C.1
Taylor, J.M.2
Sécher, S.3
-
4
-
-
83955161787
-
Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy
-
R. Miralbell, S.A. Roberts, and E. Zubizarreta Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy Int J Radiat Oncol Biol Phys 82 2012 e17 e24
-
(2012)
Int J Radiat Oncol Biol Phys
, vol.82
-
-
Miralbell, R.1
Roberts, S.A.2
Zubizarreta, E.3
-
5
-
-
18144394315
-
Is the alpha-beta ratio of prostate cancer really low? A prospective, non-randomized trial comparing standard and hyperfractionated conformal radiation therapy
-
R. Valdagni, C. Italia, and P. Montanaro Is the alpha-beta ratio of prostate cancer really low? A prospective, non-randomized trial comparing standard and hyperfractionated conformal radiation therapy Radiother Oncol 75 2005 74 82
-
(2005)
Radiother Oncol
, vol.75
, pp. 74-82
-
-
Valdagni, R.1
Italia, C.2
Montanaro, P.3
-
6
-
-
77953962354
-
The role of overall treatment time in the outcome of radiotherapy of prostate cancer: An analysis of biochemical failure in 4839 men treated between 1987 and 1995
-
H.D. Thames, D. Kuban, and L.B. Levy The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995 Radiother Oncol 96 2010 6 12
-
(2010)
Radiother Oncol
, vol.96
, pp. 6-12
-
-
Thames, H.D.1
Kuban, D.2
Levy, L.B.3
|